Corteria
Health Care
Lately:1 news story in 90 daysFollow changes →
Facts
as of Nov 17, 2026Interceptive therapies for the treatment of heart failure subpopulations. About us.
- Founded
- 2019
- Employees
- 1001-5000estimated range
- Website
- corteriapharma.com
These are the key facts about Corteria on Alion as of Nov 17, 2026. It was founded in 2019. The latest round is Series A of $70.7M, announced in 2023.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Paris France | Regional office | 0 |
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$70.7MTotal raised
Series ALatest round
1Rounds and grants
Money by yearUSD, rounds and grants
Largest rounds and grants
2023
$70.7M
Sources: funding announcements, grant and company registers
Milestones
Sep 6, 2023
Raised a round Series A $70.7M · led by OrbiMed
2019
Founded
Each milestone is dated by its source: registers, filings, the press
Newsroom
Sep 162026
Blog
We are excited to announce that preclinical data on COR-1389, the first-in-class and best-in-class CRF2 receptor agonist, will be presented at EASD 2026 in Milan! COR-1389 is des…
Jul 25, 20252025
News · usinenouvelle.com
Jul 21, 20252025
Blog
COR-1167 is entering Phase 2 clinical trial for the treatment of Worsening Heart Failure after obtaining promising Phase 1 data, while the Phase 1 of COR-1389 is ongoing for the…
Jul 21, 20252025
Jun 28, 20242024
Blog
At ESC HF 2024 in Lisbon, during an oral presentation, new data data of our CRF2 peptide agonist COR-1167 were released. On top of furosemide, COR-1167 reduced elevated cardiac f…
Sources: the outlets named on each headline, each story once
